top of page
Search

Roche buys dX company for $1B

  • Writer: John Q Leonard
    John Q Leonard
  • Mar 28, 2015
  • 1 min read

Updated: Mar 17, 2020

Diagnostics was once the red-headed step child of our industry. Therapeutics was where all the excitement was, and the money to boot. After all, it's much more exciting to cure diseases than to simply tell folks if they are sick or well.


Exit "personalized medicine" and Enter "precision medicine."

Well that all appears to have changed for several reasons. Right now, it's a great time to be in cancer diagnostics.

http://uk.reuters.com/article/2015/01/12/us-foundation-roche-idUKKBN0KL0D420150112


 
 
 

Comments


© 2021 by Leading Edge Bio

bottom of page